コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 into the bloodstream, causing the so-called "cytokine storm".
2 ponse leading to a potentially catastrophic "cytokine storm".
3 ng systemic inflammatory response, termed a 'Cytokine Storm'.
4 ce resulted in induction of rapid and lethal cytokine storm.
5 tory syndromes characterized by uncontrolled cytokine storm.
6 n thought to drive excessive inflammation in cytokine storm.
7 icity involve strain selection and a massive cytokine storm.
8 event where virus-specific T cells induce a cytokine storm.
9 participants who all developed a devastating cytokine storm.
10 rimental aspects of the influenza-associated cytokine storm.
11 g, indicating a common pathway inhibition of cytokine storm.
12 stemic uncontrolled inflammatory response or cytokine storm.
13 mechanisms that are important in initiating cytokine storm.
14 tics for infectious disease characterized by cytokine storm.
15 g endothelial cells as central regulators of cytokine storm.
16 gn therapies to attenuate a COVID-19-related cytokine storm.
17 entify new proteins involved in triggering a cytokine storm.
18 e them to be eliminated by a proinflammatory cytokine storm.
19 nsplantation to avoid the adverse effects of cytokine storm.
20 -mediated conditions are frequently termed a cytokine storm.
21 ding of similar conditions associated with a cytokine storm.
22 ociated with improved survival and decreased cytokine storm.
23 hyperactivation that has been described as a cytokine storm.
24 e to study the effects of CAR T-cell-induced cytokine storm.
25 y responses can lead to a potentially lethal cytokine storm.
26 driven by hyperactive cytokine release, or a cytokine storm.
27 mic or local inflammation with presence of a cytokine storm.
28 is by limiting the scope and duration of the cytokine storm.
29 nd can even be used for the COVID-19-related cytokine storm.
30 endoplasmic reticulum (ER) stress and robust cytokine storm.
31 COVID-19 outcomes are attributed to classic cytokine storm.
32 e circulating biomarkers associated with the cytokine storm.
33 haracterized by robust T-cell activation and cytokine storm.
34 ase 2019 in intensive care units suffer from cytokine storm.
35 d proinflammatory cytokines, consistent with cytokine storm.
36 flammation, vascular leak, organ damage, and cytokine storm.
37 ication of immune dysregulation resulting in cytokine storm.
38 uspected infection has also been viewed as a cytokine storm.
39 ers are altered as a result of infection and cytokine storm.
40 n immune responses, such as autoimmunity and cytokine storm.
41 The secondary outcome was the occurrence of cytokine storm.
42 inating NLRP3-driven pyroptosis and the sHLH cytokine storm.
43 ere clinical outcomes and the development of cytokine storm.
44 L-6 and IP-10 levels, two key players in the cytokine storm.
45 tory distress syndrome (ARDS) triggered by a cytokine storm.
46 mmatory acute stage of COVID-19 results in a cytokine storm.
47 with excessive cytokine release known as the cytokine storm.
48 lammatory mediators, representing an ongoing cytokine storm.
49 ift hyperinflammatory response typified by a cytokine storm.
50 othelial barrier disruption and uncontrolled cytokine storm.
51 y mediators implicated in the TSS-associated cytokine storm.
52 anced vascular permeability, likely due to a cytokine storm.
53 hat resulted in an elevated pro-inflammatory cytokine storm.
54 tivation in BALB/c mice was accompanied by a cytokine storm.
55 (high) monocytes and neutrophils and fuels a cytokine storm.
56 tress response and subsequent eicosanoid and cytokine storms.
57 s that adequately reduce the burden of these cytokine storms.
58 overly exuberant immune response, termed a "cytokine storm," accompanies virus-induced acute respira
59 ced hyperinflammatory response that leads to cytokine storm, acute respiratory distress syndrome (ARD
60 ma (HCC) tumor growth via an "eicosanoid and cytokine storm." AFB(1)-generated debris up-regulates cy
63 CoV-2 induced weight loss, clinical signs, a cytokine storm, an eicosanoid storm, and severe lung inf
64 e inflammation and respiratory disease, with cytokine storm and acute respiratory distress syndrome i
66 ir potent activation of T cells leading to a cytokine storm and consequently vascular leakage, shock,
67 e patients with severe Covid-19 experience a cytokine storm and display evidence of inflammasome acti
70 targeting viral entry, replication, and the cytokine storm and is associated with beneficial outcome
71 according to the receipt of tocilizumab for cytokine storm and matched to controls using propensity
72 ld identify those patients at higher risk of cytokine storm and most likely to benefit from IL-1B-neu
73 anti-CD28 antibody TGN1412 caused a massive cytokine storm and multiorgan failure in six healthy hum
76 pe, TLR7-knockout mice had attenuated plasma cytokine storm and reduced lung and hepatic injury after
81 nhibition of CeA GABAergic neurons mitigated cytokine storms and improved survival rates in lethal pn
84 Severe COVID-19 patients may experience a "cytokine storm" and associated organ damage characterize
85 combination therapy induces an intratumoral "cytokine storm" and extensive lymphocyte infiltration.
86 e of the nucleocapsid protein in triggering "cytokine storms" and severe COVID-19 that led to hospita
87 acerbated proinflammatory cytokines release (cytokine storm) and loss of T lymphocytes (leukopenia) c
88 evidence of drug-induced hypercytokinemia or cytokine storm, and at higher doses, some indication of
90 lated with the severity of COVID-19 disease, cytokine storm, and changes in myeloid cell subsets.
92 verted the molecular signature of sepsis for cytokine storm, and deregulated inflammatory reaction an
93 illness characterized by hyperinflammation, cytokine storm, and elevations of cardiac injury biomark
94 injury (ALI) characterized by vascular leak, cytokine storm, and infiltration of mononuclear cells in
97 profound, aberrant myeloid cell activation, cytokine storm, and lymphopenia, with unknown immunopath
99 also contribute to inflammatory cell death, cytokine storm, and organ damage in severe COVID-19 path
100 aberrant cell death can induce inflammation, cytokine storm, and pathology, making it a central molec
102 ory mechanisms of TLR responses relevant for cytokine storm, and suggest targeting the TBK1-IKKepsilo
103 adaptive immune response, characterized by a cytokine storm, and that it is triggered by prior SARS-C
104 oRNA combination therapy triggered transient cytokine storms, and (3) delivery of microRNA-122 and an
106 erapy, which triggers inflammatory cascades, cytokine storms, and EC dysfunction leading to acute lun
108 s untreated) had worse COVID-19 severity and cytokine storm (aOR, 3.33; 95% CI, 1.38-8.01, and aOR, 4
109 of sepsis include the inflammation-mediated cytokine storm, apoptosis-driven lymphopenia, and prolon
110 suggest that strain selection and a massive cytokine storm are major factors behind increased pathog
112 However, uncontrolled inflammation and the "cytokine storm" are hallmarks of immunopathology in seve
113 ood and Drug Administration for treatment of cytokine storm associated with chimeric antigen receptor
115 a, pneumonia, and septicemia and averted the cytokine storm associated with septic infection but had
117 ctivity, chloroquine might also mitigate the cytokine storm associated with severe pneumonia caused b
118 d with systemic inflammation often termed a "cytokine storm." Because interleukin-1 (IL-1) blocks the
119 llular restriction factor and suppression of cytokine storm: both aimed at long-term latency and host
122 agonist significantly inhibited PVM-elicited cytokine storm by blunting the PVM-specific CD8(+) T cel
124 sfunction arising from hyperinflammation and cytokine storm by processing immune cells in an extracor
125 ells infiltrated into the lung, initiating a cytokine storm by their production of gamma interferon (
126 ith the observation that COVID-19 triggers a cytokine storm capable of injuring the endothelium and d
127 -A4, Sema3A (semaphorin 3A), exacerbates the cytokine storm caused by TLR agonists and bacterial seps
128 a preponderant role in the development of a cytokine storm causing fatal consequences in coronavirus
129 t-onset Still's disease (AOSD), and COVID-19 cytokine storm (CCS) are characterized by markedly eleva
130 cute inflammatory phase of GVHD, attenuating cytokine storm, CD8+ T-cell proliferation/activation, an
131 D4(+)T cell compartment, high viremia, and a cytokine storm characterize the early days after HIV inf
132 ses including COVID-19 are associated with a cytokine storm characterized by high interleukin-6 (IL-6
134 onchoalveolar lavage fluid, and an augmented cytokine storm, compared with S1SP-treated mice on a con
135 ogressors (RDPs) had earlier and more robust cytokine storms, compared with slow disease progressors
136 ar, induction of high levels of interferon ("cytokine storms"), coupled with evasion of its effects,
139 is believed to contribute to the pathogenic cytokine storm described in severe dengue patients, but
142 evented the debris-stimulated eicosanoid and cytokine storm, down-regulated ER stress genes, and prom
145 ctively), suggesting the faster and stronger cytokine storm during AHI could promote disease progress
147 ether, these data reveal a mechanism for the cytokine storm during SARS-CoV-2 infection and suggest t
154 virus infection, robust cytokine production (cytokine storm), excessive inflammatory infiltrates, and
155 onal symptoms to a hyperinflammatory state ("cytokine storm") followed by acute respiratory distress
156 ncluding IL-6 and IFN-gamma, contribute to a cytokine storm formerly known as "toxemia." A more preci
157 ecific CD4 T cells and was associated with a cytokine storm, generalized inflammation, and multi-orga
159 During the COVID-19 pandemic, research on "cytokine storms" has been reinvigorated in the field of
161 Systemic inflammation accompanied by a "cytokine storm," hemostasis alterations and severe vascu
162 nous administration of AVIDs did not trigger cytokine storm, hepatotoxicity, or thrombocytopenia.
163 ressed secretion of HMGB1, reduced the human cytokine storm, human lymphocyte apoptosis, and rescued
164 Antioxidants alleviate oxidative stress, cytokine storm, hyperinflammation, and diminish the risk
165 mall airways, successfully demonstrating the cytokine storm, immune cell activation, epithelial cell
166 infection of Kupffer cells and the following cytokine storm.IMPORTANCE Immunocompromised human patien
168 trigger the development of MIS-C as well as cytokine storm in adult COVID-19 patients, with importan
169 odulatory interventions aimed at controlling cytokine storm in AHI may be beneficial to slow eventual
171 verproduction of reactive oxygen species and cytokine storm in COVID-19 is essential to counteract th
172 ics analyses demonstrated a massive systemic cytokine storm in COVID-MDR compared with the relatively
174 A hyperinflammatory state referred to as cytokine storm in its severest form has been marked by e
176 tial mechanism for the increased M -mediated cytokine storm in patients with T2D in response to COVID
177 tection demonstrates that BR therapy reduces cytokine storm in plasma and ELISA demonstrates reduced
180 2 transgenic mice produced a modest TH1/2/17 cytokine storm in the lung and spleen that peaked by day
181 Severe pneumonia is predominantly caused by cytokine storms in the lung, but whether this process is
182 in conjunction with alphaCD40/IL-2 prevented cytokine storms in young obese mice and protected from l
183 cytokine production in vitro and blunts the "cytokine storm" in endotoxemic mice by reducing levels o
184 on factors owing to hepatocellular necrosis, cytokine storm, increased permeability by vascular endot
185 ory state that is further propelled with the cytokine storm induced by SARS-CoV-2 infection or the lo
187 in severe cases of COVID-19, contributing to cytokine storm, inflammation, long-COVID, and other comp
188 ecan-1-null mice from the magnified systemic cytokine storm, inflammatory tissue injury, and death.
189 Inflammation markers were suggestive of cytokine storm (interleukin-6 median, 135 pg/mL) and mac
192 ests that diseases in which amplification of cytokine storm is a significant pathological component c
195 n contrast to influenza infection, where the cytokine storm is initiated early by the innate immune s
196 nia virus of mice (PVM), a model of RSV, the cytokine storm is initiated late in infection by the ada
197 rome coronavirus 2 (SARS-CoV-2) is variable, cytokine storm is observed in a subset of symptomatic in
198 g SARS-CoV-2 infection and suggests that the cytokine storm is primarily responsible for morbidity an
201 proinflammatory cytokines, but whether this cytokine storm is the main cause of fatality or is a con
202 during H5N1 influenza virus infection, the "cytokine storm" is hypothesized to be the main cause of
203 kewise, the utility of a broad term such as "cytokine storm" is that it reflects a convergence on a s
204 ne release syndrome (CRS), commonly known as cytokine storm, is an acute systemic inflammatory respon
205 ession and inflammatory gene dysregulation ("cytokine storm"), leading to systemic damage and often d
206 table approach for the effective blunting of cytokine storm, leading to the improvement of clinical a
207 rrant systemic inflammatory reaction, named "cytokine storm," leads to a detrimental impairment of th
210 sponse phase that includes an eicosanoid and cytokine storm, lung inflammation and respiratory failur
211 RS-CoV-2) pneumonia patients indicate that a cytokine storm may increase morbidity and mortality.
213 tion, most likely by reducing TLR4-dependent cytokine storm mediated by damage-associated molecular p
214 s while showing similar activities, and (ii) cytokine storm-mediated pro-inflammation (e.g. acute res
216 beneficial, an excessive activation leads to cytokine storms, multiple organ failure, and even death.
218 nt in the rats did not reproduce the massive cytokine storm observed following TGN1412 administration
219 OVID-MDR compared with the relatively milder cytokine storm observed in DRESS, while MDR did not exhi
225 onment is triggered by a chemotherapy-driven cytokine storm or through direct effects of certain chem
226 remia, sepsis, and parasitosis, limiting the cytokine storm, organ damage/dysfunction, pathogen sprea
227 S) are 2 similar diseases characterized by a cytokine storm, overwhelming inflammation, multiorgan dy
228 egulates multiple ARDS GWAS genes related to cytokine storm, oxidation, and coagulation in lung micro
230 ons uncovered the prominent direct role that cytokine storm plays in the pathogenesis, morbidity, and
231 Mouse models support the hypothesis that 'cytokine storm' plays an important role in the pathogene
236 tosis, Prf-deficient infants suffer a fatal "cytokine storm" resulting from macrophage overactivation
239 IPA analysis showed that pathogen-induced cytokine storm signaling pathway, phagosome formation, a
242 by dramatically increased bacterial burden, cytokine storm, striking histological abnormalities, and
243 TMA syndromes overlap with those released in cytokine storm, suggesting close connections between ine
244 ndromes converge upon an IL15/IL15RA-centric cytokine storm, suggestive of shared proximal pathways o
246 mic juvenile idiopathic arthritis (sJIA) and cytokine storm syndrome (CSS), a potentially fatal compl
247 ne dysregulation, in some cases resulting in cytokine storm syndrome and acute respiratory distress s
248 e activation syndrome (MAS) is a devastating cytokine storm syndrome complicating many inflammatory d
250 lays a previously unappreciated role in sHLH/cytokine storm syndrome pathogenesis by preventing macro
251 The Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to COVID-19 (ANA-COVID
252 tive conditioning regimen is hindered by the cytokine storm syndrome triggered by anti-CD3 and the hi
255 ctive benefits against hyperinflammation and cytokine storm syndrome, conditions that are associated
256 lymphohistiocytosis (sHLH), a severe form of cytokine storm syndrome, is the emergence of overactivat
258 istress syndrome (ARDS) that may progress to cytokine storm syndrome, organ dysfunction, and death.
259 atory distress syndrome that may progress to cytokine storm syndrome, organ dysfunction, and death.
272 factor and interferon-gamma) critical to the cytokine storm that amplifies expansion of donor APCs an
273 e immune cell population responsible for the cytokine storm that has been shown, in T2D, to promote e
275 xcessive inflammatory response depicted in a cytokine storm that results from invasive bacterial, fun
276 -19 induces a robust, extended inflammatory "cytokine storm" that contributes to an increased morbidi
277 eads to the severe immune dysregulation and "cytokine storm" that is characteristic of fatal ebolavir
278 al emphasis on the principal features of the cytokine storm the mechanisms underlying this intense sy
279 rheumatoid arthritis and influenza-mediated "cytokine storm." The molecular mechanism of these anti-i
281 For over two decades, we have embraced the cytokine storm theory to explain sepsis, severe sepsis a
283 erized by a type I interferon (IFN-I)-driven cytokine storm, TLR7 antagonist treatment leaves epithel
285 and peripheral inflammatory responses (i.e., cytokine storm) to infection, which might produce neuroi
289 tion leads to severe disease associated with cytokine storm, vascular dysfunction, coagulation, and p
290 hough no difference in COVID-19 severity and cytokine storm was found in the IO group compared with t
293 f proinflammatory cytokines and chemokines ('cytokine storm'), which can cause organ damage and even
294 d complications, such as lymphocytopenia and cytokine storm, which are associated with the severity o
295 lead to an aberrant inflammatory response or cytokine storm, which contributes to the severity of ill
296 e respiratory syndrome coronavirus 2-induced cytokine storm, which drives acute respiratory distress
298 fraction of T cell pools to set in motion a "cytokine storm" with severe and sometimes life-threateni
300 hrough altered T-bet dominance to dampen the cytokine storm without impeding the generation of memory